Tekla Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $11.8M | Sell |
|
|||||
|
2021
Q1 | $16.9M | Sell |
|
|||||
|
2020
Q4 | $78.4M | Buy |
|
|||||
|
2020
Q3 | $30.5M | Sell |
|
|||||
|
2020
Q2 | $43.2M | Sell |
|
|||||
|
2020
Q1 | $37.1M | Sell |
|
|||||
|
2019
Q4 | $47.1M | Sell |
|
|||||
|
2019
Q3 | $44.5M | Buy |
|
|||||
|
2019
Q2 | $52.4M | Buy |
|
|||||
|
2019
Q1 | $50.8M | Sell |
|
|||||
|
2018
Q4 | $48.3M | Buy |
|
|||||
|
2018
Q3 | $60.9M | Hold |
|
|||||
|
2018
Q2 | $54.4M | Sell |
|
|||||
|
2018
Q1 | $55.6M | Sell |
|
|||||
|
2017
Q4 | $78.9M | Sell |
|
|||||
|
2017
Q3 | $105M | Hold |
|
|||||
|
2017
Q2 | $91.4M | Sell |
|
|||||
|
2017
Q1 | $96.5M | Hold |
|
|||||
|
2016
Q4 | $97.4M | Buy |
|
|||||
|
2016
Q3 | $93.6M | Buy |
|
|||||
|
2016
Q2 | $79.6M | Buy |
|
|||||
|
2016
Q1 | $88.7M | Hold |
|
|||||
|
2015
Q4 | $121M | Hold |
|
|||||
|
2015
Q3 | $99.6M | Buy |
|
|||||
|
2015
Q2 | $106M | Buy |
|
|||||
|
2015
Q1 | $87M | Buy |
|
|||||
|
2014
Q4 | $88.3M | Buy |
|
|||||
|
2014
Q3 | $74.9M | Buy |
|
|||||
|
2014
Q2 | $52.5M | Hold |
|
|||||
|
2014
Q1 | $51.1M | Sell |
|
|||||
|
2013
Q4 | $49.4M | Hold |
|
|||||
|
2013
Q3 | $43.1M | Hold |
|
|||||
|
2013
Q2 | $34.3M | Buy |
|